Arizona continues to play an active role in COVID-19 research as new cases and hospitalizations continue their rapid rise and preparations are made to distribute vaccines. Arizona State University received a $12.5 million contract from the National Cancer Institute to help build the nation’s largest coordinated effort to study immune responses to COVID-19. And Translational Genomics Research Institute researchers found that one molecule created from a person’s DNA could be making COVID-19 infections better or worse.
Arizona company tests possible short-term COVID-19 vaccine alternative / Arizona Republic
Taiwan Semiconductor Manufacturing Co.—the world’s largest contract producer of silicon chips—is buying a large tract of undeveloped state land in north Phoenix to build its multibillion-dollar semiconductor factory.
Dr. Eric Reiman, executive director of Banner Alzheimer’s Institute in Phoenix, talks about one of the most surprising developments to emerge from a study of Colombians cursed with a gene that usually dooms its victims to full-blown Alzheimer’s disease by the age of 50.
Stem cells in umbilical cord blood could one day be used for regenerative medicine, as current clinical trials show promise for the use of umbilical cord blood to treat a host of conditions such as neurological disorders, orthopedic injuries and even diabetes. Read more: Donated cord blood saved Sophie Lee’s life, but most parents throw it away
UA creates online skin cancer prevention training for massage therapists / Arizona Public Media
Researchers at the University of Arizona have created a training program for massage therapists to identify possible signs of skin cancer.